ClinicalTrials.gov
ClinicalTrials.gov Menu
Open or close the search fields display
1 Study found for: GSK525762 in subjects with relapsed, refractory hematologic malignancies

Terms and Synonyms Searched:

Terms Search Results* Entire Database**
Synonyms
GSK525762 in subjects with relapsed, refractory hematologic malignancies 1 studies 1 studies
refractory hematologic malignancies 1 studies 67 studies
Refractory Hematologic Cancer -- 13 studies
malignancies 1 studies 69,810 studies
Tumor 1 studies 33,377 studies
Oncology 1 studies 12,136 studies
Cancer 1 studies 55,628 studies
Malignant Growth -- 2 studies
Neoplasia -- 828 studies
Neoplasm -- 54,878 studies
Neoplastic Disease -- 62 studies
neoplastic growth -- 2 studies
neoplastic syndrome -- 516 studies
hematologic 1 studies 16,889 studies
hematology 1 studies 7,839 studies
Haematologic -- 37 studies
refractory 1 studies 8,701 studies
Intractable -- 295 studies
Unresponsive -- 262 studies
relapsed 1 studies 11,736 studies
Relapse -- 7,405 studies
relapsing -- 1,326 studies
subjects 1 studies 71,892 studies
Study Participant -- 2,804 studies
GSK525762 1 studies 6 studies

   
-- No studies found
* Number of studies in the search results containing the term or synonym
** Number of studies in the entire database containing the term or synonym